Longevity of vaccination in children with chronic liver disease

ABSTRACT

Background: Superadded infection with hepatitis B virus [HBV] or hepatitis A virus [HAV] may cause serious consequences for patients with chronic liver disease [CLD]. Therefore, immunization of these patients can reduce the morbidity and mortality associated with cirrhosis. Vaccines against HBV and HAV are available; these vaccines are safe and immunogenic in healthy individuals [and in patients with CLD]